Coforge receives US Patent for compliance audit and quality assurance platform ‘Copasys'; stock rises

30 Sep 2022 , 02:06 PM

Coforge Limited announced that it has received a US patent for its proprietary solution that assists banks and financial institutions in managing risk more effectively, continuously improving business processes, and making impactful key business decisions more quickly with greater visibility and control.

Copasys, a product of Coforge, has received patent #11,256,557B1 for digitizing and automating compliance and quality assurance operations inside an organization’s enterprise risk ecosystem. Copasys is a product of Coforge’s Business Process Solutions (BPS) division.

Copasys assists organisations in leveraging cutting-edge automation technologies to simplify, maximize effectiveness, and improve the overall quality of their Enterprise Risk, Compliance, and Quality Assurance programmes.

The flexible platform architecture of Copasys includes a low-code, dynamic rule-based automation builder, simplified audit and remediation end-user modules, and dynamic BI reporting. When combined with Coforge’s AI/ML capabilities, organisations gain actionable insights to establish an Enterprise Risk Center of Excellence.

At around 2.08 PM, Coforge was trading 0.54% higher at Rs3,382 per piece, against previous close of Rs3,363.85 on NSE. The counter hit intraday high and low of Rs3,393.85 and Rs3,328.05 respectively.

For feedback and suggestions, write to us at [e-mail]